| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |